Skip to main content

Table 2 Levels of antibodies against vaccines in JIA patients depend on vaccine coverage

From: The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study

Parameters MMR vaccination for age p*
Whole group (n = 170) Incomplete (n = 50) Complete (n = 120)
Anti-measels IgG, IU/ml 0.2 (0.04; 0.53) 0.2 (0.0; 0.5) 0.2 (0.09; 0.6) 0.181
Patients with anti-measles protective IgG level, n (%) 98 (57.7) 25 (50) 73 (60.8) 0.193
Anti-mumps IgG, IU/ml 2.7 (1.2; 5.3) 1.9 (0.0; 5.1) 2.9 (1.3; 5.3) 0.101
Patients with anti-mumps protective IgG level 136 (80,0) 35 (70.0) 101 (84.2) 0.035
Anti-rubella IgG, IU/ml 79.1 (43.0; 185.1) 69.9 (36.9; 119.6) 87.3 (45.3; 198.3) 0.173
Patients with anti-rubella protective IgG level, n (%) 168 (98.2) 49 (98.0) 119 (99.2) 0.520
Time since the last MMR vaccination, years 7.3 (5.0; 10.3) 5.5 (4.0; 7.5) 7.6 (4.9; 10.6) 0.156
  Diphtheria vaccination p*
Whole group (n = 170) Incomplete (n = 85) Complete (n = 85)
Anti-diphtheria IgG, IU/ml 0.12 (0.04; 0.31) 0.07 (0.03; 0.22) 0.2 (0.06; 0.4) 0.001
Patients with anti-diphtheria protective IgG level, n (%) 88 (51,8) 34 (40.0) 54 (63.5) 0.002
Time since last diphtheria vaccination, years 6.0 (4.1; 9.6) 5.4 (4.1; 9.0) 6.1 (4.8; 9.3) 0.468
  1. *no data due to complete hepatitis B vaccination